In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures

In order to investigate the hypothesis that the combination of clarithromycin with other antibacterial agents offers a successful treatment in the eradication of Pseudomonas aeruginosa biofilm, we first determined the activity of eight antimicrobial agents against planktonic cultures of P. aeruginosa isolates by the microdilution technique. Second, we determined the in vitro effects of these antimicrobial agents individually and in combination against planktonic cultures and pre-formed biofilms of P. aeruginosa PA01. Drug combinations with marked activity were tested on biofilms of clinical isolates. The percentages of planktonic culture survival and biofilm persistence were determined using spectrophotometry and scanning electron microscopy, respectively. Bacterial enumeration was used as a more quantitative method to assess the viability of bacteria in the biofilm. Among the antibacterial agents tested, tobramycin and polymyxin B had the strongest activity against planktonic cultures when tested alone. Synergistic activity was observed for the combination chitosan/tobramycin against planktonic cultures but not biofilms, and for the combination tobramycin/clarithromycin against biofilms but not planktonic cultures. The results suggest that the combination clarithromycin/tobramycin may be successful for eradicating infections involving bacterial biofilms such as in cystic fibrosis patients chronically infected by P. aeruginosa. Further studies on representative isolates in vivo are warranted to support these results.

Medienart:

E-Artikel

Erscheinungsjahr:

2008

Erschienen:

2008

Enthalten in:

Zur Gesamtaufnahme - volume:31

Enthalten in:

International journal of antimicrobial agents - 31(2008), 4 vom: 14. Apr., Seite 329-36

Sprache:

Englisch

Beteiligte Personen:

Tré-Hardy, Marie [VerfasserIn]
Vanderbist, Francis [VerfasserIn]
Traore, Hamidou [VerfasserIn]
Devleeschouwer, Michel Jean [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Clarithromycin
Drug Combinations
H1250JIK0A
J2VZ07J96K
Journal Article
Polymyxin B
Research Support, Non-U.S. Gov't
Tobramycin
VZ8RRZ51VK

Anmerkungen:

Date Completed 15.07.2008

Date Revised 01.12.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijantimicag.2007.12.005

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM177668822